137 related articles for article (PubMed ID: 38396892)
1. Antibiotic Combination to Effectively Postpone or Inhibit the In Vitro Induction and Selection of Levofloxacin-Resistant Mutants in
Lee CC; Lai CH; Yang CH; Huang YH; Lin JN
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396892
[TBL] [Abstract][Full Text] [Related]
2. Mutant Prevention Concentrations of Ciprofloxacin and Levofloxacin and Target Gene Mutations of Fluoroquinolones in Elizabethkingia anophelis.
Lin IF; Lai CH; Lin SY; Lee CC; Lee NY; Liu PY; Yang CH; Huang YH; Lin JN
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0030122. PubMed ID: 35708332
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis.
Jian MJ; Cheng YH; Chung HY; Cheng YH; Yang HY; Hsu CS; Perng CL; Shang HS
J Antimicrob Chemother; 2019 Jun; 74(6):1503-1510. PubMed ID: 30830171
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.
Lin JN; Lai CH; Yang CH; Huang YH; Lin HH
J Antimicrob Chemother; 2018 Sep; 73(9):2497-2502. PubMed ID: 29846598
[TBL] [Abstract][Full Text] [Related]
5. Comparative Genomics and Antimicrobial Resistance Profiling of
Burnard D; Gore L; Henderson A; Ranasinghe A; Bergh H; Cottrell K; Sarovich DS; Price EP; Paterson DL; Harris PNA
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580952
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against
Lin JN; Lai CH; Huang YH; Yang CH
Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33801839
[No Abstract] [Full Text] [Related]
7. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
[TBL] [Abstract][Full Text] [Related]
9. Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
Nathania I; Nainggolan IM; Yasmon A; Nusatia ACM; Tjoa E; Gunardi WD; Moehario LH
BMC Microbiol; 2022 Oct; 22(1):250. PubMed ID: 36253712
[TBL] [Abstract][Full Text] [Related]
10. Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anophelis.
Tang HJ; Lin YT; Chen CC; Chen CW; Lu YC; Ko WC; Chen HJ; Su BA; Chang PC; Chuang YC; Lai CC
J Antimicrob Chemother; 2021 Apr; 76(5):1205-1214. PubMed ID: 33532826
[TBL] [Abstract][Full Text] [Related]
11. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].
Zhang FF; Zhao CJ; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004-2005 to 2014-2015.
Schmitz J; van der Linden M; Al-Lahham A; Levina N; Pletz MW; Imöhl M
Int J Med Microbiol; 2017 Jun; 307(4-5):216-222. PubMed ID: 28506425
[TBL] [Abstract][Full Text] [Related]
13. Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
Muramatsu H; Horii T; Takeshita A; Hashimoto H; Maekawa M
Chemotherapy; 2005 May; 51(2-3):70-5. PubMed ID: 15870499
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.
Spigaglia P; Barbanti F; Louie T; Barbut F; Mastrantonio P
Antimicrob Agents Chemother; 2009 Jun; 53(6):2463-8. PubMed ID: 19364867
[TBL] [Abstract][Full Text] [Related]
15. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
17. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
[TBL] [Abstract][Full Text] [Related]
18. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.
Jorgensen JH; Weigel LM; Ferraro MJ; Swenson JM; Tenover FC
Antimicrob Agents Chemother; 1999 Feb; 43(2):329-34. PubMed ID: 9925527
[TBL] [Abstract][Full Text] [Related]
19. Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis.
Lee YL; Hsueh PR
Curr Opin Infect Dis; 2023 Dec; 36(6):481-494. PubMed ID: 37548375
[TBL] [Abstract][Full Text] [Related]
20. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
